←Back to Expert Scholars
Translational Medicine / 转化医学Desmoid Tumor
Mrinal Gounder
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Associate Attending Physician, Sarcoma and Rare Cancers
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mrinal Gounder led the DeFi trial demonstrating efficacy of the gamma-secretase inhibitor nirogacestat in desmoid tumors, leading to FDA approval. He has been a leader in rare cancer drug development at Memorial Sloan Kettering.
Share:
🧪Research Fields 研究领域
nirogacestat
DeFi trial
gamma-secretase inhibitors
desmoid fibromatosis
rare sarcoma trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mrinal Gounder 的研究动态
Follow Mrinal Gounder's research updates
留下邮箱，当我们发布与 Mrinal Gounder（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment